Elizabeth Holmes Sentenced To More Than 11 Years For Defrauding Theranos Investors Of Hundreds Of Millions

SAN JOSE – Elizabeth A. Holmes was sentenced today to 135 months (11 years, 3 months) in federal prison for defrauding investors in Theranos, Inc. of hundreds of millions of dollars, announced United States Attorney Stephanie M. Hinds, Federal Bureau of Investigation Special Agent in Charge Robert K. Tripp, Food and Drug Administration (FDA) Assistant Commissioner for Criminal Investigations...

Sameday Health settles with LA over fake COVID-19 test results

Los Angeles – Calling alleged actions by a COVID-19 testing company a serious violation of public trust, City Attorney Mike Feuer has announced two settlements valued at a total of $26,454,593. One settlement for $22.5 million resolved allegations that the Venice-based national COVID-testing chain Sameday Technologies (doing business as Sameday Health) and its CEO Felix Huettenbach faked and forged...

SEC Charges Biotech Company and CEO With Fraud Concerning COVID-19 Blood Testing Device

Washington D.C., Dec. 18, 2020 — The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended...

Merck Announces Sale of Direct Equity Investment in Moderna

Merck Announces Sale of Direct Equity Investment in Moderna
Merck Declares Sale of Direct Fairness Funding in Moderna Merck introduced in the present day that it divested its direct holding in Moderna within the first half of the fourth quarter of 2020. Merck, which had invested $50 million in Moderna in 2015 and a further $125 million in 2018, mentioned it might retain oblique publicity by way of its enterprise...

Moderna CEO Bancel Confident of Producing 500 Million COVID-19 Vaccine Doses in 2021

Moderna Inc will have the ability to produce 500 million doses of its COVID-19 vaccine in 2021, Chief Government Officer Stéphane Bancel mentioned on Friday. The corporate has submitted purposes in search of emergency use authorization in the US and the European Union after full outcomes from a late-stage examine confirmed the vaccine was 94.1% efficient with no severe security...

3 Ways To Play the Healthcare Surge

biotech healthcare stock
BioTech and Healthcare will be big players in 2020 US stocks have rocketed 28% this year. This is the second largest annual gain since 1999. And the tenth straight year stocks have climbed higher. This has a lot of investors worried that stocks could tank soon. But this bull market is far from over. My research shows stocks should continue to rise until...

How to Invest in Biotech Stocks

Biotech Stock
How to Invest in Biotech Stocks 7 simple steps to improving your chances of success in biotech investing Exciting. Scary. Lucrative. Risky. All of these adjectives apply to investing in biotech stocks. The excitement and the prospects for generating huge profits make biotech stocks appealing to many investors. On the other hand, the fear of big losses that stem from the high...

Opioid manufacturer Insys files for bankruptcy after $225m settlement

insys opioid files chapter 11
Opioid manufacturer Insys files for bankruptcy after $225m settlement A leading drug maker, whose founder and top executives have been convicted of bribing doctors to prescribe a highly addictive painkiller, has become the first opioid manufacturer to declare bankruptcy after being hit with huge fines. On Monday, Insys Therapeutics filed for Chapter 11 bankruptcy protection while it sells off its assets after...

5 Cannabis Companies Reporting Soon that You Should be Watching

cannabis companies reporting
5 Cannabis Companies Reporting Soon that You Should be Watching This week and next week, some very important upstarts in the cannabis industry will be reporting. The pending release of revenue numbers is highly anticipated as the nascent cannabis industry's pricing and multiple is largely constructed on square-footage, pending sales, and just sheer speculation. So, this week is a crucial...